PP_1170x120_10-25-21

Jeffrey Woldt editor-in-chief Chain Drug Review

Video Forum: Brian Nightengale, NACDS and Good Neighbor Pharmacy

Video Forum: Brian Nightengale, NACDS and Good Neighbor Pharmacy

  Brian Nightengale, the incoming chairman of the National Association of Chain Drug Stores and head of AmerisourceBergen’s Good Neighbor Pharmacy network, tells this week’s Video Forum about how he views NACDS’ role in the industry and outlines his priorities for the association. Securing relief from burdensome DIR fees, expanding the scope of pharmacy practice

Retailing overhaul not limited to drug stores

Retailing overhaul not limited to drug stores

In the last issue of Chain Drug Review, this space was devoted to an assessment of brick-and-mortar drug stores’ future in the wake of market dynamics forever changed by the COVID pandemic, the pressing need to revamp health care delivery in America, and shoppers’ enthusiastic embrace of digital technology. Chain drug retailers were praised for

Video Forum: George Rafferty and Claire Biermaas, AmerisourceBergen, Part 2

Video Forum: George Rafferty and Claire Biermaas, AmerisourceBergen, Part 2

  This week’s Video Forum features the second installment of a two-part interview with George Rafferty and Claire Biermaas, president and vice president of corporate partnerships, respectively, at AmerisourceBergen. Among the subjects they discuss are the importance of communication and diversity of thought in finding the best solutions for customers, the enhancement of the technology

Recent news from Washington a mixed bag for retailers

Recent news from Washington a mixed bag for retailers

Two recent developments in the nation’s capitol — one at the Centers for Medicare and Medicaid Services, the other at the Supreme Court — merit close scrutiny from pharmacy operators and other large retailers. Impacting different aspects of the business, each of the moves by the federal government has the potential to produce significant consequences

Reining in big business has its pitfalls

Reining in big business has its pitfalls

President Biden last month signed an executive order intended to limit the clout of big business and enhance competitive prospects for small and mid-sized companies. The sweeping document — which includes 72 specific elements, among them provisions instructing the Food and Drug Administration to clear the way for prescription drug imports from Canada (a very

Video Forum: Rick Keyes, Meijer

Video Forum: Rick Keyes, Meijer

In the first of three episodes leading up to the NACDS Annual Meeting later this month, Video Forum talks with Rick Keyes, president and CEO of Meijer Inc., about his year as the association’s chairman. Among the topics discussed are chain pharmacy’s response to COVID-19, other issues of importance to the industry and NACDS’ ability

Maintaining relevance will require change

Maintaining relevance will require change

As more Americans get vaccinated against COVID-19 every day and hope for a restoration of pre-pandemic conditions intensifies, pharmacy operators are thinking about how their stores will fit into the retail landscape as the new normal takes shape. Consumer behavior has changed considerably over the past 12 months, as restrictions on businesses and risk aversion

Video Forum: Jon Roberts, CVS Health

Video Forum: Jon Roberts, CVS Health

In this week’s Video Forum, Jon Roberts, chief operating officer of CVS Health, discusses the company’s unique health care model and its performance during the COVID-19 crisis. He also addresses the response of patients and payers to CVS’ HealthHUB format, the important place that front-end merchandise has in the company’s retail strategy, and the impact

Video Forum: Clint Mahlman, London Drugs

Video Forum: Clint Mahlman, London Drugs

Clint Mahlman, president and chief operating officer of London Drugs, tells this week’s Video Forum how the drug chain’s unique business model meets a variety of needs for consumers in Western Canada, especially during the COVID-19 outbreak. He also discusses the boom in e-commerce, an area in which London Drugs has more than two decades

Private sector gets serious about a sustainable future

Private sector gets serious about a sustainable future

CDR SPECIAL REPORT — Since the beginning of the COVID-19 pandemic, the momentum behind the sustainability movement has slowed somewhat, with the attention of government officials, activists and average citizens dominated by the immediate crisis and the concurrent drive for racial justice. The climate emergency has not, however, abated, a reality brought home to Americans

Video Forum: NACDS’ Steve Anderson

Video Forum: NACDS’ Steve Anderson

The COVID-19 pandemic has placed unprecedented demands on retail pharmacies. In the first of Chain Drug Review’s new series of video interviews, NACDS president and chief executive officer Steve Anderson talks about how the industry has responded to the challenge, the lessons being learned from the experience, and what the association’s priorities will be when